Skip to main content
. 2010 Jun 1;54(8):3280–3286. doi: 10.1128/AAC.00306-10

TABLE 3.

Comparison of 3TC-derived pharmacokinetic parameters between our study and the latest publications of data from HIV-1-infected children

Study (reference) Group Dose Value for parametera:
Cmin (mg/liter) Cmax (mg/liter) AUC0→τ (mg/liter·h) CL/F (liters/h/kg)
l'Homme et al. (14) Mean age, 6.9 yr (n = 65) 4 mg/kg q12h 0.09 1.33 [0.69] 5.42 [2.26]
Burger et al. (5) Median age, 3.8 yr (IQR, 2.5-4.8 yr) (n = 17) 4 mg/kg q12h 0.07 (0.06-0.08) 0.98 (0.82-1.43) 3.71 (3.44-6.17) 1.03 (0.67-1.22)
Burger et al. (5) Median age, 10.1 yr (IQR 8.5-12.3 yr) (n = 34) 4 mg/kg q12h 0.09 (0.07-0.11) 1.84 (1.21-2.28) 6.54 (5.21-8.58) 0.57 (0.45-0.74)
Bergshoeff et al. (4) Age, 2.1-12.8 yr (n = 19) 4 mg/kg q12h 0.067 1.11 (0.96-1.29) 4.44 (3.83-5.14) 0.90 (0.78-1.04)
Bergshoeff et al. (4) Age, 2.1-12.8 yr (n = 19) 8 mg/kg q24h 0.05 2.09 (1.80-2.42) 9.80 (8.64-11.12) 0.80 (0.70-0.92)
This study Age, 2.5-14 yr (n = 45) 8 mg/kg q24h 0.04 (0.01-0.14) 1.7 (1.34-2.01) 7.8 (4.72-14.27) 1.03 (0.55-1.62)
a

Values for the study by l'Homme et al. (14) are given as means [standard deviation]. All other values are median values, with interquartile ranges (IQR) shown in parentheses.